期刊文献+

Preparation and preliminary biological evaluation of ^(99m)Tc-ANMdU 被引量:1

Preparation and preliminary biological evaluation of ^(99m)Tc-ANMdU
下载PDF
导出
摘要 Technetium-99m-labeled-5-{2-sulfanylethyl-[2-(2-sulfanylethylamino)acetyl]amino}-methyl-2′-deoxy- uridine (99mTc-ANMdU) was reported. The precursor ANMdU was synthesized by six-step reactions and all intermediates were verified with MS and 1HNMR. Using SnCl2 as reducing agent, a labeling reaction was carried out at 100°C for 30 min. The radiochemical purity of the 99mTc-ANMdU was 96.68%. Partition coefficients were 0.92 and 0.70 at pH 7.0 and 7.4 of the phosphate buffer saline, respectively. Biodistribution of 99mTc-ANMdU in normal mice showed that the initial uptake of 99mTc-ANMdU in vivo and the clearance was rapid. Technetium-^99m-labeled-5- {2-sulfanylethyl- [2-(2-sulfanylethylamino)acetyl]amino }-methyl-2'-deoxy- uridine (^99mTc-ANMdU) was reported. The precursor ANMdU was synthesized by six-step reactions and all intermediates were verified with MS and 1HNMR. Using SnCl2 as reducing agent, a labeling reaction was carried out at 100℃ for 30 min. The radiochemical purity of the ^99mTc-ANMdU was 96.68%. Partition coefficients were 0.92 and 0.70 at pH 7.0 and 7.4 of the phosphate buffer saline, respectively. Biodistribution of ^99mTc-ANMdU in normal mice showed that the initial uptake of ^99mTc-ANMdU in vivo and the clearance was rapid.
出处 《Nuclear Science and Techniques》 SCIE CAS CSCD 2010年第2期106-109,共4页 核技术(英文)
基金 Supported by National Natural Science Foundation of China (20573048 and 20676051) Natural Science Foundation of Jiangsu Province (BK2008111, BK2008112) Department of Health of Jiangsu Province (H200624)
关键词 生物制备 放射化学纯度 评价 磷酸盐缓冲液 1HNMR 氯化亚锡 分配系数 中间体 Synthesis, ^99mTc-ANMdU, Biodistribution, A thymidine analog
  • 相关文献

参考文献12

  • 1Shields A F,Grierson J R,Dohmen B M,et al.Nat Med,1998,4(11):1334-1336. 被引量:1
  • 2Kubota R,Yamada S,Kubota K,et al.J Nucl Med,1992,33(11):1972-1980. 被引量:1
  • 3Lu L,Samuelsson L,Bergstrfm M,et al.J Nucl Med,2002,43(12):1688-1698. 被引量:1
  • 4Shields A F,J Nucl Med,2003,44(9):1432-1434. 被引量:1
  • 5Barthel H,Perumal M,Latigo J,et al.Eur J Nucl Med Mol Imaging,2005,32(3):257-263. 被引量:1
  • 6Barthel H,Cleij M C,Collingridge,D R,et al.Cancer Res,2003,63(13):3791-3798. 被引量:1
  • 7Chen W,Cloughesy T,Kamdar N,et al.J Nucl Med,2005,46(6):945-952. 被引量:1
  • 8Sun H,Sloan A,Mangner T J,et al.Eur J Nucl Med Mol Imaging,2005,32(1):15-22. 被引量:1
  • 9Zhang Y,Dai X,Kallmes D F,et al.Tetrahedron Lett,2004,45(47):8673-8676. 被引量:1
  • 10Teng B,Bai Y,Chang Y,et al.Bioorgan Med Chem Lett,2007,17(12):3440-3444. 被引量:1

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部